Spandonaro F - Search Results

1

Refining sorafenib therapy: lessons from clinical practice.

Bolondi L, Craxi A, Trevisani F, Daniele B, Di Costanzo GG, Fagiuoli S, Cammà C, Bruzzi P, Danesi R, Spandonaro F, Boni C, Santoro A, Colombo M. Bolondi L, et al. Among authors: spandonaro f. Future Oncol. 2015;11(3):449-65. doi: 10.2217/fon.14.261. Epub 2014 Oct 31. Future Oncol. 2015. PMID: 25360997 Free article. Review.

2

The role of procalcitonin outside of the Intensive Care Unit (ICU): a multidisciplinary approach.

Fantoni M, Taddei E, Cauda R, Antonelli Incalzi R, Capone A, Cortese F, Sanguinetti M, Spandonaro F, Urbani A, Murri R. Fantoni M, et al. Among authors: spandonaro f. Eur Rev Med Pharmacol Sci. 2019 Apr;23(7):2978-2985. doi: 10.26355/eurrev_201904_17579. Eur Rev Med Pharmacol Sci. 2019. PMID: 31002168 Free article.

3

Analysing outpatient care access for planning purposes: The Basilicata Region experience.

Brenna E, Polistena B, Spandonaro F. Brenna E, et al. Among authors: spandonaro f. Eval Program Plann. 2023 Aug;99:102315. doi: 10.1016/j.evalprogplan.2023.102315. Epub 2023 May 18. Eval Program Plann. 2023. PMID: 37210952 Free article.

4

Prevalence of Prostate Cancer at Different Clinical Stages in Italy: Estimated Burden of Disease Based on a Modelling Study.

Spandonaro F, D'Angela D, Polistena B, Bruzzi P, Iacovelli R, Luccarini I, Stagni P, Brigido A. Spandonaro F, et al. Biology (Basel). 2021 Mar 10;10(3):210. doi: 10.3390/biology10030210. Biology (Basel). 2021. PMID: 33801914 Free PMC article.

5

Health-related quality of life in psoriasis: an analysis of Psocare project patients.

Spandonaro F, Altomare G, Berardesca E, Calzavara-Pinton P, Chimenti S, Girolomoni G, Peserico A, Guerra AP, Vena GA, Polistena B, Ayala F. Spandonaro F, et al. G Ital Dermatol Venereol. 2011 Jun;146(3):169-77. G Ital Dermatol Venereol. 2011. PMID: 21566546

6

The cost effectiveness of biologic therapy for the treatment of chronic plaque psoriasis in real practice settings in Italy.

Spandonaro F, Ayala F, Berardesca E, Chimenti S, Girolomoni G, Martini P, Peserico A, Polistena B, Puglisi Guerra A, Vena GA, Altomare G, Calzavara Pinton P. Spandonaro F, et al. BioDrugs. 2014 Jun;28(3):285-95. doi: 10.1007/s40259-014-0084-3. BioDrugs. 2014. PMID: 24567261 Free PMC article.

7

[Hospitalization for acute heart failure].

Polistena B, Lattarulo M, Spandonaro F, Testa T, d'Angela D. Polistena B, et al. Among authors: spandonaro f. G Ital Cardiol (Rome). 2014 Feb;15(2 Suppl 2):16S-21S. doi: 10.1714/1465.16185. G Ital Cardiol (Rome). 2014. PMID: 24770485 Italian.

8

[Acute heart failure clinical pathways, hospital funding and accreditation standards].

Carbone G, Casciato S, Spandonaro F, d'Angela D. Carbone G, et al. Among authors: spandonaro f. G Ital Cardiol (Rome). 2014 Feb;15(2 Suppl 2):22S-31S. doi: 10.1714/1465.16187. G Ital Cardiol (Rome). 2014. PMID: 24770486 Italian.

9

[Cost-effectiveness and budget impact of ivabradine in heart failure therapy].

Polistena B, Maggioni AP, Oliva F, Spandonaro F. Polistena B, et al. Among authors: spandonaro f. G Ital Cardiol (Rome). 2014 Nov;15(11):626-33. doi: 10.1714/1694.18508. G Ital Cardiol (Rome). 2014. PMID: 25424141 Italian.

10

Reply to Scalone and Cortesi: "Cost-utility analysis of biologic therapies to treat chronic plaque psoriasis in Italy: the importance of using updated and adequate social tariffs to calculate QALYs".

Spandonaro F, Ayala F, Berardesca E, Chimenti S, Girolomoni G, Martini P, Peserico A, Polistena B, Guerra AP, Vena GA, Altomare G, Pinton PC. Spandonaro F, et al. BioDrugs. 2015 Feb;29(1):71-2. doi: 10.1007/s40259-015-0118-5. BioDrugs. 2015. PMID: 25647521 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53 results

Search Page